Burak H Alsan, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Emerson Hospital - · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alsan’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A126971 · Current
Licensed to practise in California · since 2013 · expires 2029-02-28 · Loyola University of Chicago Stritch School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Emerson Hospital -W Concord, MAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Emerson Hospital Health SystemPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.255, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Emerson Hospital -
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.255 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.13 to 2.13) · 751 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.59 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.76 (87.33 to 208.2) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.2 · 294 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 455 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 16.1 · 149 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 2,097 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 4,387 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 4,398 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.59 (1.24 to 5.95) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.01 (0.4 to 3.62) · 631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.31 (2.01 to 18.6) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.49 (0.47 to 8.52) · 225 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2 (0.51 to 3.5) · 181 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.63 (0 to 1.55) · 2,870 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 54 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.398 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.63 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 387 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -10.7 · 362 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -6.6 · 508 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 531 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.8 (4 to 8.3) · 233 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.2 (10.7 to 18.6) · 233 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 44 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 22.3 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.4 to 17.6) · 980 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 694 cases | No different | Jan 2024 – Dec 2024 |
What patients said (563 patients answered, 25% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$30,766
Medicare paid this office $30,766 for 95 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 53 | $9,841 | $99 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 59 | $8,334 | $141 |
| Short return visit (20+ min) | 34 | $3,417 | $71 |
| Influenza vaccine split virus, preservative free | 19 | $1,545 | $81 |
| Administration of influenza virus vaccine | 19 | $671 | $35 |
See all 7 services
| Return visit (30+ min) | 53 | $9,841 | $99 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 59 | $8,334 | $141 |
| Short return visit (20+ min) | 34 | $3,417 | $71 |
| Influenza vaccine split virus, preservative free | 19 | $1,545 | $81 |
| Administration of influenza virus vaccine | 19 | $671 | $35 |
| Annual alcohol misuse screening, 5 to 15 minutes | 19 | $404 | $21 |
| Annual depression screening, 5 to 15 minutes | 19 | $404 | $21 |
Who their Medicare patients are
95 Original Medicare patients in 2024. Average age 76 · Women 38% · Health risk score 1.01. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 61% · Coronary heart disease 22% · Chronic kidney disease 22% · Atrial fibrillation 20% · Depression 20% · Diabetes 19% · Cancer 18% · Heart failure 14%.
The office billed $141,704, Medicare allowed $37,236 and paid $30,766; for 346 services of 30 kinds; $4,146 of it was for drugs given in the office and $26,620 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 95 | 346 | 76 | 1.01 | $141,704 | $30,766 |
| 2023 | 85 | 252 | 74 | 0.91 | $105,239 | $23,941 |
| 2022 | 34 | 48 | 73 | 0.68 | $20,564 | $5,543 |
| 2017 | 66 | 125 | 70 | 2.00 | $22,413 | $7,735 |
| 2016 | 172 | 342 | 70 | 1.70 | $72,102 | $22,808 |
| 2015 | 252 | 465 | 71 | 1.54 | $92,553 | $31,488 |
| 2014 | 220 | 378 | 70 | 1.41 | $74,683 | $23,193 |
| 2013 | 88 | 115 | 72 | 1.27 | $21,276 | $7,249 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 35 | $5,999 | $103 |
| Short return visit (20+ min) | 40 | $4,000 | $73 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,404 | $142 |
| Long return visit (40+ min) | 13 | $2,652 | $147 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $2,263 | $206 |
| New patient visit (45+ min) | 12 | $1,303 | $109 |
| Influenza vaccine split virus, preservative free | 11 | $575 | $52 |
| Administration of influenza virus vaccine | 11 | $372 | $34 |
| Administration of pneumococcal vaccine | 11 | $372 | $34 |
2022: 1 service
| New patient visit (60+ min) | 11 | $2,109 | $192 |
2017: 2 services
| Return visit (30+ min) | 55 | $5,692 | $63 |
| Short return visit (20+ min) | 20 | $866 | $39 |
2016: 3 services
| Return visit (30+ min) | 125 | $13,648 | $63 |
| Long return visit (40+ min) | 62 | $6,419 | $77 |
| Short return visit (20+ min) | 19 | $1,185 | $44 |
2015: 3 services
| Return visit (30+ min) | 164 | $17,889 | $63 |
| Long return visit (40+ min) | 81 | $9,383 | $96 |
| Short return visit (20+ min) | 58 | $2,647 | $38 |
2014: 4 services
| Return visit (30+ min) | 150 | $13,873 | $62 |
| Short return visit (20+ min) | 72 | $3,373 | $39 |
| Long return visit (40+ min) | 25 | $2,467 | $88 |
| New patient visit (45+ min) | 16 | $1,735 | $108 |
2013: 2 services
| Return visit (30+ min) | 53 | $4,216 | $67 |
| Short return visit (20+ min) | 30 | $1,446 | $43 |
Medicaid work
$7,401 in 2019
Medicaid paid $7,401 for 102 billed services this clinician did in 2019, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 43 | $3,909 |
| Return visit (30+ min) | 59 | $3,492 |
| 2019 | 102 | 2 | 17 | $7,401 |
| 2018 | 261 | 2 | 26 | $20,321 |
See the largest Medicaid services in earlier years
2018
| Long return visit (40+ min) | 141 | $13,427 |
| Return visit (30+ min) | 120 | $6,894 |
Drugs they prescribed that Part D paid
$158,015
Pharmacies billed $158,015 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (29 of 1,514) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
1,333 generic and fewer than 11 brand-name prescriptions · $158,015 in drug cost · 36 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 30 | $24,762 | $825 |
| Xarelto | 17 | $19,569 | $1,151 |
| Jardiance | 17 | $16,819 | $989 |
| Farxiga | 13 | $7,550 | $581 |
| Atorvastatin | 124 | $2,208 | $18 |
See all 37 drugs
| Eliquis | 30 | $24,762 | $825 |
| Xarelto | 17 | $19,569 | $1,151 |
| Jardiance | 17 | $16,819 | $989 |
| Farxiga | 13 | $7,550 | $581 |
| Atorvastatin | 124 | $2,208 | $18 |
| Metoprolol | 47 | $1,166 | $25 |
| Lantus Solostar | 11 | $848 | $77 |
| Levothyroxine | 45 | $819 | $18 |
| Amlodipine Besylate | 94 | $805 | $9 |
| Gabapentin | 38 | $730 | $19 |
| Tamsulosin | 35 | $719 | $21 |
| Pravastatin | 28 | $624 | $22 |
| Ezetimibe | 13 | $544 | $42 |
| Rosuvastatin | 30 | $512 | $17 |
| Lisinopril | 83 | $503 | $6 |
| Buspirone | 13 | $495 | $38 |
| Omeprazole | 35 | $479 | $14 |
| Losartan | 30 | $452 | $15 |
| Temazepam | 15 | $448 | $30 |
| Trazodone | 33 | $419 | $13 |
| Chlorthalidone | 11 | $362 | $33 |
| Simvastatin | 26 | $325 | $12 |
| Triamterene-Hydrochlorothiazid | 17 | $269 | $16 |
| Sertraline | 17 | $264 | $16 |
| Oxycodone | 12 | $262 | $22 |
| Albuterol Sulfate Hfa | 11 | $248 | $23 |
| Fluoxetine | 18 | $240 | $13 |
| Hydrochlorothiazide | 21 | $219 | $10 |
| Metformin | 23 | $190 | $8 |
| Finasteride | 13 | $182 | $14 |
| Rabeprazole | 11 | $151 | $14 |
| Clonazepam | 16 | $150 | $9 |
| Spironolactone | 11 | $149 | $14 |
| Tramadol | 14 | $142 | $10 |
| Metoprolol | 16 | $50 | $3 |
| Lorazepam | 14 | $44 | $3 |
| Zolpidem | 18 | $22 | $1 |
Year by year
| 2024 | 1,514 | 228 | 2% (29) | None | $158,015 |
| 2023 | 1,029 | 218 | 1% (14) | 10% | $97,530 |
| 2022 | 26 | 14 | 0% (0) | None | $5,579 |
| 2018 | 212 | 60 | 0% (0) | 16% | $10,059 |
| 2017 | 1,463 | 168 | 6% (92) | None | $112,190 |
| 2016 | 2,208 | 277 | 7% (147) | None | $159,619 |
| 2015 | 1,787 | 280 | 10% (177) | None | $110,410 |
| 2014 | 1,119 | 223 | 9% (97) | None | $70,526 |
| 2013 | 1,468 | 168 | 9% (135) | 13% | $56,677 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Xarelto | 11 | $11,397 | $1,036 |
| Jardiance | 12 | $11,111 | $926 |
| Eliquis | 13 | $9,899 | $761 |
| Atorvastatin | 83 | $2,317 | $28 |
| Memantine | 19 | $1,499 | $79 |
| Metoprolol | 30 | $915 | $31 |
| Tamsulosin | 30 | $806 | $27 |
| Lisinopril | 55 | $646 | $12 |
| Albuterol Sulfate Hfa | 14 | $480 | $34 |
| Pravastatin | 17 | $452 | $27 |
| Levothyroxine | 26 | $449 | $17 |
| Omeprazole | 27 | $407 | $15 |
| Amlodipine Besylate | 41 | $406 | $10 |
| Losartan | 17 | $391 | $23 |
| Donepezil | 18 | $305 | $17 |
| Simvastatin | 22 | $274 | $12 |
| Gabapentin | 19 | $260 | $14 |
| Fluoxetine | 17 | $240 | $14 |
| Trazodone | 18 | $224 | $12 |
| Furosemide | 14 | $204 | $15 |
| Atenolol | 18 | $196 | $11 |
| Metformin | 12 | $166 | $14 |
| Paxlovid (Eua) | 13 | $141 | $11 |
| Metoprolol | 18 | $124 | $7 |
| Citalopram Hbr | 11 | $98 | $9 |
| Sertraline | 22 | $97 | $4 |
| Finasteride | 13 | $68 | $5 |
| Lorazepam | 12 | $47 | $4 |
2018: 4 drugs
| Atorvastatin | 19 | $261 | $14 |
| Amlodipine Besylate | 12 | $103 | $9 |
| Metformin | 11 | $54 | $5 |
| Atenolol | 11 | $48 | $4 |
2017: 46 drugs
| Creon | 18 | $12,802 | $711 |
| Cialis | 16 | $4,990 | $312 |
| Colchicine | 12 | $3,734 | $311 |
| Crestor | 11 | $2,852 | $259 |
| Voltaren | 23 | $1,879 | $82 |
| Atorvastatin | 83 | $1,830 | $22 |
| Tamsulosin | 38 | $1,159 | $31 |
| Gabapentin | 42 | $1,145 | $27 |
| Levothyroxine | 36 | $1,065 | $30 |
| Duloxetine | 22 | $999 | $45 |
| Valsartan | 21 | $925 | $44 |
| Hydrocodone-Acetaminophen | 36 | $892 | $25 |
| Omeprazole | 45 | $830 | $18 |
| Rosuvastatin | 16 | $769 | $48 |
| Losartan | 34 | $690 | $20 |
| Oxycodone-Acetaminophen | 11 | $632 | $57 |
| Metoprolol | 16 | $622 | $39 |
| Montelukast | 13 | $436 | $34 |
| Amlodipine Besylate | 52 | $417 | $8 |
| Fluocinonide | 11 | $413 | $38 |
| Pravastatin | 11 | $307 | $28 |
| Simvastatin | 13 | $304 | $23 |
| Diclofenac | 14 | $302 | $22 |
| Lisinopril | 36 | $269 | $7 |
| Warfarin | 19 | $254 | $13 |
| Trazodone | 14 | $250 | $18 |
| Pantoprazole | 16 | $243 | $15 |
| Tramadol | 26 | $220 | $8 |
| Atenolol | 23 | $208 | $9 |
| Metformin | 30 | $200 | $7 |
| Citalopram Hbr | 11 | $182 | $17 |
| Terazosin | 14 | $169 | $12 |
| Allopurinol | 11 | $167 | $15 |
| Sotalol | 13 | $165 | $13 |
| Triamcinolone Acetonide | 11 | $144 | $13 |
| Chlorhexidine Gluconate | 15 | $133 | $9 |
| Promethazine | 12 | $118 | $10 |
| Lorazepam | 18 | $115 | $6 |
| Metoprolol | 22 | $112 | $5 |
| Prednisone | 12 | $111 | $9 |
| Hydrochlorothiazide | 31 | $110 | $4 |
| Selenium Sulfide | 12 | $87 | $7 |
| Topiramate | 11 | $84 | $8 |
| Furosemide | 16 | $79 | $5 |
| Alprazolam | 13 | $64 | $5 |
| Zolpidem | 16 | $63 | $4 |
2016: 61 drugs
| Emsam | 11 | $16,595 | $1,509 |
| Lyrica | 16 | $12,641 | $790 |
| Creon | 18 | $8,142 | $452 |
| Advair Diskus | 18 | $7,222 | $401 |
| Cialis | 17 | $5,274 | $310 |
| Hydrocodone-Acetaminophen | 82 | $4,479 | $55 |
| Valsartan | 22 | $3,548 | $161 |
| Crestor | 13 | $3,227 | $248 |
| Atorvastatin | 110 | $3,179 | $29 |
| Lidocaine | 15 | $2,986 | $199 |
| Voltaren | 25 | $1,823 | $73 |
| Cozaar | 13 | $1,812 | $139 |
| Fluocinonide | 19 | $1,755 | $92 |
| Gabapentin | 68 | $1,617 | $24 |
| Levothyroxine | 50 | $1,521 | $30 |
| Tamsulosin | 38 | $1,319 | $35 |
| Proair Hfa | 12 | $1,176 | $98 |
| Sumatriptan | 15 | $1,133 | $76 |
| Duloxetine | 18 | $1,125 | $63 |
| Amlodipine Besylate | 100 | $1,116 | $11 |
| Propranolol Hcl Er | 11 | $1,102 | $100 |
| Oxycodone-Acetaminophen | 15 | $1,034 | $69 |
| Omeprazole | 73 | $1,004 | $14 |
| Metoprolol | 19 | $861 | $45 |
| Allopurinol | 29 | $640 | $22 |
| Lisinopril | 70 | $607 | $9 |
| Losartan | 43 | $560 | $13 |
| Fluticasone Propionate | 36 | $497 | $14 |
| Potassium Chloride | 19 | $495 | $26 |
| Trazodone | 18 | $493 | $27 |
| Pantoprazole | 34 | $431 | $13 |
| Montelukast | 21 | $400 | $19 |
| Pravastatin | 14 | $369 | $26 |
| Clopidogrel | 15 | $350 | $23 |
| Atenolol | 40 | $316 | $8 |
| Azelastine | 14 | $309 | $22 |
| Digox | 11 | $305 | $28 |
| Tramadol | 29 | $291 | $10 |
| Mirtazapine | 18 | $272 | $15 |
| Metformin | 36 | $266 | $7 |
| Zolpidem | 26 | $250 | $10 |
| Baclofen | 13 | $190 | $15 |
| Glipizide Er | 15 | $185 | $12 |
| Prednisone | 20 | $164 | $8 |
| Triamcinolone Acetonide | 13 | $159 | $12 |
| Carvedilol | 11 | $151 | $14 |
| Ranitidine | 14 | $135 | $10 |
| Citalopram Hbr | 11 | $134 | $12 |
| Hydrochlorothiazide | 39 | $133 | $3 |
| Sotalol | 13 | $128 | $10 |
| Simvastatin | 13 | $128 | $10 |
| Metoprolol | 23 | $122 | $5 |
| Furosemide | 27 | $113 | $4 |
| Naproxen | 13 | $99 | $8 |
| Lorazepam | 15 | $90 | $6 |
| Ondansetron | 13 | $88 | $7 |
| Alprazolam | 15 | $83 | $6 |
| Diazepam | 12 | $51 | $4 |
| Chlorhexidine Gluconate | 19 | $48 | $3 |
| Famotidine | 11 | $33 | $3 |
| Topiramate | 13 | $28 | $2 |
2015: 38 drugs
| Lyrica | 18 | $8,002 | $445 |
| Creon | 15 | $5,722 | $381 |
| Cialis | 14 | $5,100 | $364 |
| Hydrocodone-Acetaminophen | 90 | $4,750 | $53 |
| Atorvastatin | 98 | $2,585 | $26 |
| Duloxetine | 14 | $1,773 | $127 |
| Levothyroxine | 59 | $1,624 | $28 |
| Tamsulosin | 37 | $1,438 | $39 |
| Omega-3 Acid Ethyl Esters | 11 | $1,385 | $126 |
| Fentanyl | 11 | $1,192 | $108 |
| Amlodipine Besylate | 101 | $1,025 | $10 |
| Voltaren | 21 | $986 | $47 |
| Omeprazole | 85 | $959 | $11 |
| Polyethylene Glycol 3350 | 14 | $890 | $64 |
| Gabapentin | 30 | $653 | $22 |
| Losartan | 55 | $625 | $11 |
| Fluticasone Propionate | 37 | $544 | $15 |
| Zolpidem | 28 | $522 | $19 |
| Metoprolol | 17 | $470 | $28 |
| Lisinopril | 50 | $363 | $7 |
| Simvastatin | 23 | $363 | $16 |
| Mirtazapine | 11 | $335 | $30 |
| Pantoprazole | 21 | $331 | $16 |
| Labetalol | 12 | $331 | $28 |
| Allopurinol | 32 | $312 | $10 |
| Oxycodone | 11 | $305 | $28 |
| Metformin | 39 | $304 | $8 |
| Tramadol | 29 | $288 | $10 |
| Atenolol | 30 | $232 | $8 |
| Indomethacin | 12 | $211 | $18 |
| Oxycodone-Acetaminophen | 11 | $204 | $19 |
| Hydrochlorothiazide | 19 | $170 | $9 |
| Furosemide | 18 | $114 | $6 |
| Alprazolam | 15 | $107 | $7 |
| Carisoprodol | 12 | $103 | $9 |
| Lorazepam | 13 | $91 | $7 |
| Prednisone | 12 | $50 | $4 |
| Diazepam | 11 | $40 | $4 |
2014: 26 drugs
| Crestor | 24 | $7,215 | $301 |
| Creon | 16 | $6,234 | $390 |
| Dexilant | 11 | $2,029 | $184 |
| Hydrocodone-Acetaminophen | 45 | $1,313 | $29 |
| Atorvastatin | 51 | $1,272 | $25 |
| Omeprazole | 43 | $679 | $16 |
| Levothyroxine | 23 | $652 | $28 |
| Amlodipine Besylate | 53 | $572 | $11 |
| Gabapentin | 20 | $401 | $20 |
| Alendronate | 18 | $360 | $20 |
| Mirtazapine | 13 | $346 | $27 |
| Fluticasone Propionate | 17 | $311 | $18 |
| Zolpidem | 23 | $276 | $12 |
| Lisinopril | 40 | $251 | $6 |
| Losartan | 14 | $209 | $15 |
| Nortriptyline | 15 | $190 | $13 |
| Simvastatin | 19 | $169 | $9 |
| Metformin | 26 | $158 | $6 |
| Tramadol | 12 | $154 | $13 |
| Carvedilol | 16 | $136 | $8 |
| Atenolol | 23 | $134 | $6 |
| Trazodone | 13 | $118 | $9 |
| Prednisone | 13 | $107 | $8 |
| Methadone | 13 | $105 | $8 |
| Hydrochlorothiazide | 13 | $51 | $4 |
| Diazepam | 14 | $35 | $3 |
2013: 39 drugs
| Keppra | 12 | $4,249 | $354 |
| Lantus | 15 | $4,146 | $276 |
| Advair Diskus | 11 | $3,655 | $332 |
| Morphine Sulfate Er | 17 | $1,055 | $62 |
| Clopidogrel | 16 | $1,003 | $63 |
| Oxycodone | 19 | $940 | $49 |
| Omeprazole | 76 | $848 | $11 |
| Atorvastatin | 31 | $821 | $26 |
| Gabapentin | 37 | $766 | $21 |
| Lisinopril | 122 | $702 | $6 |
| Metoprolol | 21 | $678 | $32 |
| Oxycodone-Acetaminophen | 33 | $597 | $18 |
| Simvastatin | 66 | $542 | $8 |
| Metformin | 70 | $485 | $7 |
| Tamsulosin | 28 | $441 | $16 |
| Tramadol | 29 | $417 | $14 |
| Amlodipine Besylate | 66 | $405 | $6 |
| Verapamil Er | 29 | $378 | $13 |
| Methadone | 14 | $318 | $23 |
| Fluticasone Propionate | 11 | $284 | $26 |
| Finasteride | 15 | $272 | $18 |
| Atenolol | 45 | $224 | $5 |
| Alendronate | 23 | $215 | $9 |
| Alprazolam | 23 | $215 | $9 |
| Nortriptyline | 14 | $213 | $15 |
| Chlorthalidone | 15 | $210 | $14 |
| Sertraline | 19 | $200 | $11 |
| Lisinopril-Hydrochlorothiazide | 20 | $195 | $10 |
| Clonazepam | 25 | $185 | $7 |
| Glipizide | 26 | $183 | $7 |
| Ibuprofen | 20 | $175 | $9 |
| Pravastatin | 15 | $165 | $11 |
| Ranitidine | 22 | $161 | $7 |
| Naproxen | 22 | $158 | $7 |
| Hydrochlorothiazide | 30 | $136 | $5 |
| Metformin Hcl Er | 14 | $128 | $9 |
| Paroxetine | 12 | $117 | $10 |
| Levothyroxine | 17 | $117 | $7 |
| Enalapril Maleate | 19 | $88 | $5 |
Professional record
- NPI
- 1669508073
- Licence
- CA A126971, MA 239175California A126971: Current · expires 2029-02-28
- Trained
- Loyola University of Chicago, Stritch School of Medicine, 2005
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Pediatrics (208000000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-02-27
- NPI last updated
- 2026-09-08
- NPI record certified
- 2026-09-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 80 Beharrell St, Concord, MA, 01742